Neogen (NEOG) EBT (2010 - 2026)
Neogen's (NEOG) quarterly EBT came in at -$20.3 million in Q1 2026, down 109.28% year-on-year from $218.8 million in Q1 2025, and little changed quarter-over-quarter from -$20.4 million in Q4 2025.
Neogen (NEOG) EBT (2010 - 2026) Analysis & Trends
Neogen's EBT history runs 17 years deep, the most recent figure standing at -$20.3 million for Q1 2026.
- On a quarterly basis, EBT fell 109.28% year-over-year to -$20.3 million in Q1 2026; TTM through Feb 2026 was -$628.1 million, a 23.57% decrease from a year earlier, with the FY2025 full-year figure at -$1.1 billion, down 7821.08% from the prior year.
- EBT steadied at -$20.3 million in Q1 2026 per NEOG's latest filing, from -$20.4 million in the prior quarter.
- Across five years, EBT topped out at $43.8 million in Q3 2025 and bottomed at -$631.2 million in Q2 2025.
- The 5-year median for EBT is -$5.8 million (2024), against an average of -$67.1 million.
- Across the five-year window, EBT tumbled 12618.76% in 2024 and jumped 380.66% in 2025, its largest moves.
- Year by year, EBT stood at -$34.1 million in 2022, then soared by 89.01% to -$3.7 million in 2023, then tumbled by 12618.76% to -$476.6 million in 2024, then soared by 95.73% to -$20.4 million in 2025, then climbed by 0.31% to -$20.3 million in 2026.
- Per Business Quant, the three latest NEOG EBT figures stand at -$20.3 million (Q1 2026), -$20.4 million (Q4 2025), and $43.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.45 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 850.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.83 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.16 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 459.00 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 269.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 222.44 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 505.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Neogen | 2.09 Bn | 1.93 Bn | 99.00 Mn | -20.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -20.30 Mn |
| Nov 30, 2025 | -20.36 Mn |
| Aug 31, 2025 | 43.81 Mn |
| May 31, 2025 | -631.21 Mn |
| Feb 28, 2025 | -9.70 Mn |
| Nov 30, 2024 | -476.57 Mn |
| Aug 31, 2024 | -15.61 Mn |
| May 31, 2024 | -6.40 Mn |
| Feb 29, 2024 | -5.82 Mn |
| Nov 30, 2023 | -3.75 Mn |
| Aug 31, 2023 | 1.66 Mn |
| May 31, 2023 | 7.65 Mn |
| Feb 28, 2023 | -2.26 Mn |
| Nov 30, 2022 | -34.09 Mn |
| Aug 31, 2022 | 6.66 Mn |
| May 31, 2022 | 18.91 Mn |
| Feb 28, 2022 | 6.64 Mn |
| Nov 30, 2021 | 12.93 Mn |
| Aug 31, 2021 | 21.73 Mn |
| May 31, 2021 | 20.15 Mn |